Soru

Zorluk: KolayMenstrual Cycle Abnormalities and Contraception

A 46-year-old woman is evaluated in the outpatient clinic for a 5-month history of heavy and irregular vaginal bleeding. She states that her menstrual cycles were previously regular, occurring every 28 days and lasting 5 days, but they now occur at random intervals with heavy flow and the passage of large blood clots. Her medical history includes type 2 diabetes mellitus, hypertension, and obesity. Current medications are metformin and lisinopril. Her body mass index is 36 kg/m236 \text{ kg/m}^2. Vital signs are within normal limits. Pelvic examination demonstrates a normal-appearing vagina and cervix, with a normal-sized, non-tender uterus and no palpable adnexal masses. A point-of-care urine beta-hCG test is negative. Which of the following is the most appropriate next step in management?

  1. Endometrial biopsyCevap
  2. B
    Transvaginal ultrasonography
  3. C
    Prescription of combined oral contraceptive pills
  4. D
    Measurement of serum thyroid-stimulating hormone
  5. E
    Reassurance and observation

Cevap

Endometrial biopsy
This patient presents with abnormal uterine bleeding (AUB). In any woman aged 45 years or older with AUB, the risk of endometrial hyperplasia and endometrial cancer is significantly elevated. Therefore, current clinical guidelines mandate that the first and most appropriate step in management is an endometrial biopsy. This patient also has additional significant risk factors for endometrial cancer, specifically her obesity and type 2 diabetes mellitus, which lead to increased peripheral conversion of androgens to estrogens, creating an environment of unopposed estrogen. A definitive tissue diagnosis must be established to rule out malignancy before initiating any medical therapy or further structural workup.

Adım Adım Çözüm

1
Identify the patient's primary presenting symptom and demographic risk factors.
The patient is a 46-year-old woman with new-onset abnormal uterine bleeding (AUB), obesity, and type 2 diabetes.
Age and metabolic profile strongly influence the differential diagnosis for AUB.
2
Evaluate the initial diagnostic testing.
The urine beta-hCG is negative, completely ruling out complications of pregnancy as the etiology for the bleeding.
Pregnancy must be universally excluded in all premenopausal women with abnormal bleeding before proceeding down other diagnostic algorithms.
3
Apply the age-based clinical guidelines for abnormal uterine bleeding.
Guidelines mandate that all women ≥45\geq 45 years of age with AUB must undergo endometrial tissue sampling.
The risk of endometrial hyperplasia and cancer increases significantly at this age, and tissue diagnosis is required before initiating any symptomatic medical management.

Anahtar Kavram

Evaluation of abnormal uterine bleeding (AUB) in women aged 45 years and older requires an endometrial biopsy as the first-line diagnostic step to rule out endometrial hyperplasia and cancer.
Bu soruyu puanla